Quest Diagnostics
DGX
#1090
Rank
โ‚น1.473 T
Marketcap
โ‚น13,198
Share price
1.86%
Change (1 day)
17.02%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Earnings for Quest Diagnostics (DGX)

Earnings in 2024 (TTM): โ‚น92.86 Billion

According to Quest Diagnostics 's latest financial reports the company's current earnings are โ‚น9.53 Billion. In 2023 the company made an earning of โ‚น95.91 Billion a decrease over its 2022 earnings that were of โ‚น104.82 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quest Diagnostics from 1997 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น92.86 B-3.18%
2023 โ‚น95.91 B-8.5%
2022 โ‚น104.82 B-52.48%
2021 โ‚น220.60 B37.95%
2020 โ‚น159.91 B75.09%
2019 โ‚น91.33 B16.2%
2018 โ‚น78.59 B-10.1%
2017 โ‚น87.42 B-5.16%
2016 โ‚น92.17 B-1.54%
2015 โ‚น93.62 B31%
2014 โ‚น71.46 B-37.52%
2013 โ‚น114.39 B26.93%
2012 โ‚น90.12 B24.01%
2011 โ‚น72.67 B-27.7%
2010 โ‚น100.52 B-3.55%
2009 โ‚น104.22 B19.59%
2008 โ‚น87.15 B12.54%
2007 โ‚น77.44 B-11.7%
2006 โ‚น87.70 B13.49%
2005 โ‚น77.27 B9.02%
2004 โ‚น70.88 B13.19%
2003 โ‚น62.62 B36.03%
2002 โ‚น46.03 B63.07%
2001 โ‚น28.23 B65.49%
2000 โ‚น17.05 B1297.84%
1999 โ‚น1.22 B-73.37%
1998 โ‚น4.58 B-384.21%
1997 -โ‚น1.62 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น69.79 B-26.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น0.26 Billion-100.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น5.99 Billion-106.33%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น0.84 Billion-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.53 B-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น13.52 B-85.69%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands